Blanchette CM - Search Results

1

Cost and utilization of COPD and asthma among insured adults in the US.

Blanchette CM, Broder M, Ory C, Chang E, Akazawa M, Dalal AA. Blanchette CM, et al. Curr Med Res Opin. 2009 Jun;25(6):1385-92. doi: 10.1185/03007990902875927. Curr Med Res Opin. 2009. PMID: 19419342

2

Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.

Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L. Blanchette CM, et al. Am J Geriatr Pharmacother. 2008 Aug;6(3):138-46. doi: 10.1016/j.amjopharm.2008.08.005. Am J Geriatr Pharmacother. 2008. PMID: 18775388

3

Hospital and emergency department utilization associated with treatment for chronic obstructive pulmonary disease in a managed-care Medicare population.

Simoni-Wastila L, Yang HW, Blanchette CM, Zhao L, Qian J, Dalal AA. Simoni-Wastila L, et al. Among authors: blanchette cm. Curr Med Res Opin. 2009 Nov;25(11):2729-35. doi: 10.1185/03007990903267157. Curr Med Res Opin. 2009. PMID: 19778165

4

Adherence to controller therapy for chronic obstructive pulmonary disease: a review.

Charles MS, Blanchette CM, Silver H, Lavallee D, Dalal AA, Mapel D. Charles MS, et al. Among authors: blanchette cm. Curr Med Res Opin. 2010 Oct;26(10):2421-9. doi: 10.1185/03007995.2010.516284. Curr Med Res Opin. 2010. PMID: 20815661 Review.

5

Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.

Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M. Blanchette CM, et al. J Manag Care Pharm. 2008 Mar;14(2):176-85. doi: 10.18553/jmcp.2008.14.2.176. J Manag Care Pharm. 2008. PMID: 18331119 Free PMC article.

6

Burden of concomitant asthma and COPD in a Medicaid population.

Shaya FT, Dongyi D, Akazawa MO, Blanchette CM, Wang J, Mapel DW, Dalal A, Scharf SM. Shaya FT, et al. Among authors: blanchette cm. Chest. 2008 Jul;134(1):14-9. doi: 10.1378/chest.07-2317. Epub 2008 Mar 13. Chest. 2008. PMID: 18339789

7

Economic burden prior to COPD diagnosis: a matched case-control study in the United States.

Akazawa M, Halpern R, Riedel AA, Stanford RH, Dalal A, Blanchette CM. Akazawa M, et al. Among authors: blanchette cm. Respir Med. 2008 Dec;102(12):1744-52. doi: 10.1016/j.rmed.2008.07.009. Epub 2008 Aug 28. Respir Med. 2008. PMID: 18760581 Free article.

8

Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies.

Delea TE, Hagiwara M, Dalal AA, Stanford RH, Blanchette CM. Delea TE, et al. Among authors: blanchette cm. Curr Med Res Opin. 2009 Jan;25(1):1-13. doi: 10.1185/03007990802534020. Curr Med Res Opin. 2009. PMID: 19210134

9

Healthcare costs associated with initial maintenance therapy with fluticasone propionate 250 μg/salmeterol 50 μg combination versus anticholinergic bronchodilators in elderly US Medicare-eligible beneficiaries with COPD.

Dalal AA, Petersen H, Simoni-Wastila L, Blanchette CM. Dalal AA, et al. Among authors: blanchette cm. J Med Econ. 2009;12(4):339-47. doi: 10.3111/13696990903369135. J Med Econ. 2009. PMID: 19827993 Free article.

10

The role of combination inhaled corticosteroid/long-acting beta-agonist therapy in COPD management.

Mapel DW, Hurley JS, Dalal AA, Blanchette CM. Mapel DW, et al. Among authors: blanchette cm. Prim Care Respir J. 2010 Jun;19(2):93-103. doi: 10.4104/pcrj.2010.00020. Prim Care Respir J. 2010. PMID: 20339822 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters